darutoside: from Siegesbeckia glabrescens Mak; RN given refers to (2R-(2alpha,4aalpha,4bbeta,7alpha(R*),10abeta)) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 146159280 |
| MeSH ID | M0173893 |
| Synonym |
|---|
| darutoside |
| 59219-65-7 |
| Excerpt | Reference |
|---|---|
| " The present method was successfully applied to the pharmacokinetic study of kirenol in male Sprague-Dawley rats after oral administration at a dose of 50 mg/kg." | ( A rapid and simple RP-HPLC method for quantification of kirenol in rat plasma after oral administration and its application to pharmacokinetic study. Fu, HZ; Qian, RQ; Song, XL; Wang, ZM; Zhang, QY, 2011) |
| Excerpt | Reference |
|---|---|
| " Darutoside possesses the activity of termination of early pregnancy in experimental rats at a dosage of 20-40 mg/kg." | ( [Studies on antifertility constituents of Siegesbeckia glabrescens Mak]. Chen, M; Dong, XY; Huang, DX; Jin, W; Li, HT; Shen, SM, 1989) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||